R. Bonn

464 total citations
34 papers, 326 citations indexed

About

R. Bonn is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Analytical Chemistry. According to data from OpenAlex, R. Bonn has authored 34 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 11 papers in Cardiology and Cardiovascular Medicine and 10 papers in Analytical Chemistry. Recurrent topics in R. Bonn's work include Analytical Methods in Pharmaceuticals (10 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Heart Failure Treatment and Management (7 papers). R. Bonn is often cited by papers focused on Analytical Methods in Pharmaceuticals (10 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Heart Failure Treatment and Management (7 papers). R. Bonn collaborates with scholars based in Germany, Ireland and Belgium. R. Bonn's co-authors include Willi Cawello, Horst Schweer, Volkmar Schulz, L. F. Chasseaud, Jochen Kindler, H. W. Seyberth, R. M�ller, K. Greeff, Dietmar Trenk and A. Darragh and has published in prestigious journals such as European Heart Journal, British Journal of Clinical Pharmacology and Drug Metabolism and Disposition.

In The Last Decade

R. Bonn

32 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Bonn Germany	10	85	59	52	48	33	34	326
F. Follath Switzerland	13	72 0.8×	72 1.2×	57 1.1×	101 2.1×	24 0.7×	17	535
Hannu Sundquist Finland	12	103 1.2×	52 0.9×	19 0.4×	80 1.7×	56 1.7×	15	514
Klaus D. Raemsch Germany	6	90 1.1×	61 1.0×	18 0.3×	54 1.1×	71 2.2×	8	376
M. Guerret France	13	60 0.7×	56 0.9×	22 0.4×	58 1.2×	60 1.8×	26	374
A. McBurney United Kingdom	16	55 0.6×	156 2.6×	43 0.8×	59 1.2×	30 0.9×	38	679
R. Calvo Spain	14	32 0.4×	83 1.4×	39 0.8×	65 1.4×	43 1.3×	47	538
G Hitzenberger Austria	9	80 0.9×	79 1.3×	26 0.5×	65 1.4×	23 0.7×	53	340
G. Groenewoud South Africa	12	42 0.5×	49 0.8×	25 0.5×	60 1.3×	22 0.7×	32	378
J. Pabst Germany	9	136 1.6×	26 0.4×	27 0.5×	37 0.8×	76 2.3×	19	310
Richard J. Fruncillo United States	12	65 0.8×	145 2.5×	23 0.4×	166 3.5×	26 0.8×	29	719

Countries citing papers authored by R. Bonn

Since Specialization

Citations

This map shows the geographic impact of R. Bonn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Bonn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Bonn more than expected).

Fields of papers citing papers by R. Bonn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Bonn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Bonn. The network helps show where R. Bonn may publish in the future.

Co-authorship network of co-authors of R. Bonn

This figure shows the co-authorship network connecting the top 25 collaborators of R. Bonn. A scholar is included among the top collaborators of R. Bonn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Bonn. R. Bonn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Michaelis, Karl, et al.. (1996). Lack of a pharmacokinetic interaction between moexipril and hydrochlorothiazide. European Journal of Clinical Pharmacology. 51(3-4). 339–344. 1 indexed citations

Trenk, Dietmar, et al.. (1994). Pharmacokinetics and haemodynamic effects of ISDN following different dosage forms and routes of administration. European Journal of Clinical Pharmacology. 46(4). 319–24. 8 indexed citations

Cawello, Willi, Horst Schweer, R. M�ller, R. Bonn, & H. W. Seyberth. (1994). Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjects. European Journal of Clinical Pharmacology. 46(3). 275–7. 50 indexed citations

Hood, Ashley J., et al.. (1994). Metabolic fate of¹⁴C-camostat mesylate in man, rat and dog after intravenous administration. Xenobiotica. 24(1). 79–92. 37 indexed citations

Pabst, G, et al.. (1994). Bioequivalence evaluation of the metabolites 1,2 and 1,3-glyceryl dinitrate of two different glyceryl trinitrate patches after 12-h usage in healthy volunteers.. PubMed. 44(12). 1317–21. 5 indexed citations

Schnellbacher, K., et al.. (1993). Comparison of the effects of two different galenical preparations of glyceryl trinitrate on pulmonary artery pressure and on the finger pulse curve. European Journal of Clinical Pharmacology. 44(5). 451–456. 13 indexed citations

Pabst, G, et al.. (1993). Bioavailability and pharmacokinetics of a new isosorbide dinitrate spray preparation in healthy volunteers.. PubMed. 43(8). 842–6.

Bonn, R., et al.. (1992). Pharmacodynamic and Pharmacokinetic Evaluation of a New Transdermal Delivery System with a Time‐Dependent Release of Glyceryl Trinitrate. The Journal of Clinical Pharmacology. 32(1). 77–84. 9 indexed citations

Pabst, G, et al.. (1992). Evaluation of Bioavailability and Pharmacokinetics of Two Isosorbide‐5‐Mononitrate Preparations in Healthy Volunteers. The Journal of Clinical Pharmacology. 32(6). 553–557. 3 indexed citations

10.

Bonn, R., et al.. (1991). Haemodynamic effects of glyceryl trinitrate following repeated application of a transdermal delivery system with a phasic release profile. European Journal of Clinical Pharmacology. 41(2). 115–8. 7 indexed citations

11.

Bonn, R., et al.. (1989). Principles of transdermal nitroglycerin administration. European Heart Journal. 10(suppl A). 26–29. 11 indexed citations

12.

Evers, Josef, et al.. (1989). Pharmacokinetics of isosorbide dinitrate, isosorbide-2-nitrate and isosorbide-5-nitrate in renal insufficiency after repeated oral dosage. Journal of Molecular Medicine. 67(6). 342–348. 1 indexed citations

13.

Wood, Stuart, B. A. John, L. F. Chasseaud, et al.. (1987). Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog. Xenobiotica. 17(7). 881–896. 5 indexed citations

14.

Cawello, Willi & R. Bonn. (1987). Determination of captopril in plasma and urine. Fresenius Zeitschrift für Analytische Chemie. 327(1). 29–30. 1 indexed citations

15.

Noack, E., Willi Cawello, & R. Bonn. (1987). Kinetic studies of the tissue binding tendency of the new vasodilator pildralazine.. PubMed. 37(4). 407–9. 1 indexed citations

16.

Bonn, R., et al.. (1987). Determination of glycerol trinitrate and its metabolites in plasma by capillary gas liquid Chromatography. Fresenius Zeitschrift für Analytische Chemie. 327(1). 28–29. 3 indexed citations

17.

Evers, Josef, et al.. (1987). Pharmacokinetics of isosorbide-5-nitrate during haemodialysis and peritoneal dialysis. European Journal of Clinical Pharmacology. 32(5). 503–505. 7 indexed citations

18.

Cawello, Willi & R. Bonn. (1983). [The effect on biologic availability of the choice of infusion material in nitroglycerin therapy].. PubMed. 33(4). 595–7. 4 indexed citations

19.

Bonn, R. & Willi Cawello. (1982). Bestimmung von Propyldazin in biologischen Flüssigkeiten. Fresenius Zeitschrift für Analytische Chemie. 311(4). 408–408.

20.

Bonn, R. & K. Greeff. (1978). The effect of chronic administration of digitoxin on the activity of the myocardial (Na + K)-ATPase in guinea-pigs.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 233(1). 53–64. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact